Triethanolamine
- Generic Name
- Triethanolamine
- Brand Names
- Tru-micin
- Drug Type
- Small Molecule
- Chemical Formula
- C6H15NO3
- CAS Number
- 102-71-6
- Unique Ingredient Identifier
- 9O3K93S3TK
- Background
Trolamine, which is also referred to as triethanolamine (TEA), is a tertiary amine and a triol. It is a bifunctional compound that exhibits both properties of alcohols and amines. Trolamine contains small amounts of diethanolamine and ethanolamine and may also act as an antioxidant against the auto-oxidation of animal and vegetable fats . It is commonly used as a pH adjuster and surfactant in industrial and cosmetic products such as skin and hair conditioning products.
- Indication
Trolamine is used as an alkalizing agent, surfactant, and counter-ion in cosmetic and pharmaceutical formulations . It is not considered to be an active pharmacological ingredient and so has no official indication.
- Associated Conditions
- Pain
- Associated Therapies
- Skin disinfection, Topical Analgesia
Efficacy of Fullerene in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer .
- Conditions
- Radiation Dermatitis
- Interventions
- Other: Fullerene cream
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 132
- Registration Number
- NCT06484166
Clinical Observation of Drug Retention Enema in Preventing Acute Radiation-induced Rectal Injury
- Conditions
- Rectal DiseasesRadiation Injuries
- Interventions
- First Posted Date
- 2024-03-22
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- Fujian Cancer Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06325982
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
- Conditions
- RadiodermatitisNasopharyngeal Neoplasms
- Interventions
- Drug: Medical Radiation Protectants (FORRAD®)
- First Posted Date
- 2016-04-06
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- Yun-fei Xia
- Target Recruit Count
- 136
- Registration Number
- NCT02729324
- Locations
- 🇨🇳
Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.